Warning: The NCBI web site requires JavaScript to function. more...
Estrogen receptor of primary breast cancers: evidence for intracellular proteolysis.
Maaroufi Y, Lacroix M, Lespagnard L, Journé F, Larsimont D, Leclercq G.
Breast Cancer Res. 2000;2(6):444-54. Epub 2000 Sep 6.
Related citations
Major molecular weight heterogeneity of estrogen receptor from breast cancer is not related to neoplasia.
Maaroufi Y, Trivedi S, Leclercq G.
Cancer Biochem Biophys. 1995 Nov;15(2):67-78.
Evidence of an estrogen receptor form devoid of estrogen binding ability in MCF-7 cells.
El Khissiin A, Journé F, Laïos I, Seo HS, Leclercq G.
Steroids. 2000 Dec;65(12):903-13.
Detection of different estrogen receptor forms in breast cancer cytosol by enzyme immunoassay.
Dittadi R, Meo S, Amoroso B, Gion M.
Cancer Res. 1997 Mar 15;57(6):1066-72.
Immunodetection of nmt55/p54nrb isoforms in human breast cancer.
Pavao M, Huang YH, Hafer LJ, Moreland RB, Traish AM.
BMC Cancer. 2001;1:15. Epub 2001 Oct 29.
Expression and cellular localization of naturally occurring beta estrogen receptors in uterine and mammary cell lines.
Monje P, Boland R.
J Cell Biochem. 2002;86(1):136-44.
[Expression and intranuclear distribution of nucleolin in estrogen receptor-negative and estrogen receptor-positive breast cancers in women measured by laser scanning cytometry].
Masiuk M.
Ann Acad Med Stetin. 2006;52(2):23-32. Polish.
Importance of A/B and C domains of the estrogen receptor for its adsorption to hydroxylapatite.
Maaroufi Y, Leclercq G.
J Steroid Biochem Mol Biol. 1994 Jan;48(1):155-63.
Estrogen and growth factor receptor interactions in human breast and non-small cell lung cancer cells.
Pietras RJ, Márquez DC, Chen HW, Tsai E, Weinberg O, Fishbein M.
Steroids. 2005 May-Jun;70(5-7):372-81. Epub 2005 Mar 25.
MICoA, a novel metastasis-associated protein 1 (MTA1) interacting protein coactivator, regulates estrogen receptor-alpha transactivation functions.
Mishra SK, Mazumdar A, Vadlamudi RK, Li F, Wang RA, Yu W, Jordan VC, Santen RJ, Kumar R.
J Biol Chem. 2003 May 23;278(21):19209-19. Epub 2003 Mar 14.
Downregulation of nuclear expression of the p33(ING1b) inhibitor of growth protein in invasive carcinoma of the breast.
Nouman GS, Anderson JJ, Crosier S, Shrimankar J, Lunec J, Angus B.
J Clin Pathol. 2003 Jul;56(7):507-11.
Breast cancer proteomics reveals correlation between estrogen receptor status and differential phosphorylation of PGRMC1.
Neubauer H, Clare SE, Wozny W, Schwall GP, Poznanovic S, Stegmann W, Vogel U, Sotlar K, Wallwiener D, Kurek R, Fehm T, Cahill MA.
Breast Cancer Res. 2008;10(5):R85. Epub 2008 Oct 15. Erratum in: Breast Cancer Res. 2009;11(1):401.
Detection of the oestrogen receptor (ER). immunohistochemical versus cytosol measurements.
Leake R.
Eur J Cancer. 2000 Sep;36 Suppl 4:S18-9.
Molecular assay to generate expression profile of eight estrogen receptor alpha isoform mRNA copy numbers in picogram amounts of total RNA from breast cancer tissues.
Poola I.
Anal Biochem. 2003 Mar 15;314(2):217-26.
The immunocytochemical versus cytosol measurement of the oestrogen receptor in invasive breast cancer tissue.
Gordts SL, Neven P, Van Hooff I, Tonglet R, Laurent C, Marechal S, De Muylder X, Van Belle Y, Vanderick G.
Eur J Cancer. 2000 Sep;36 Suppl 4:S20-1.
Expression of osteoprotegerin (OPG), TNF related apoptosis inducing ligand (TRAIL), and receptor activator of nuclear factor kappaB ligand (RANKL) in human breast tumours.
Van Poznak C, Cross SS, Saggese M, Hudis C, Panageas KS, Norton L, Coleman RE, Holen I.
J Clin Pathol. 2006 Jan;59(1):56-63.
Differential expression of two estrogen receptor beta isoforms in the human fetal testis during the second trimester of pregnancy.
Gaskell TL, Robinson LL, Groome NP, Anderson RA, Saunders PT.
J Clin Endocrinol Metab. 2003 Jan;88(1):424-32.
Selective reduction of estrogen receptor (ER) positive breast cancer occurrence by estrogen receptor modulators supports etiological distinction between ER positive and ER negative breast cancers.
Kurbel S.
Med Hypotheses. 2005;64(6):1182-7.
A candidate molecular signature associated with tamoxifen failure in primary breast cancer.
Vendrell JA, Robertson KE, Ravel P, Bray SE, Bajard A, Purdie CA, Nguyen C, Hadad SM, Bieche I, Chabaud S, Bachelot T, Thompson AM, Cohen PA.
Breast Cancer Res. 2008;10(5):R88. Epub 2008 Oct 17.
Expression and regulation of Cyr61 in human breast cancer cell lines.
Tsai MS, Bogart DF, Li P, Mehmi I, Lupu R.
Oncogene. 2002 Jan 31;21(6):964-73.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on